Medical expert of the article
New publications
Streptoderma: forms, symptoms and progression characteristics
Last updated: 27.10.2025
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Impetigo is a superficial bacterial skin infection, most often caused by Streptococcus pyogenes, that presents with honey-colored crusts, erosions, and sometimes ulcers in a deeper form called ecthyma. The condition is highly contagious, but with proper treatment, it is usually benign and heals without leaving any marks, except in cases of ecthyma, where scarring is possible. [1]
Despite the "classical" association of the term with streptococci, the clinical reality is that non-bullous impetigo is often of mixed origin, involving Streptococcus pyogenes and Staphylococcus aureus, whereas bullous impetigo is almost always caused by Staphylococcus aureus and its desquamative toxins. Therefore, the physician considers coverage of both pathogens when choosing empirical therapy. [2]
The main goal of treatment is to shorten the duration of symptoms, limit spread within families and communities, and prevent rare immune complications, such as post-streptococcal glomerulonephritis. Properly selected topical or systemic antibiotics shorten the period of infectivity and reduce the risk of transmission. [3]
The disease is more common in children, but can occur at any age. Peak incidence occurs during warm and humid months, associated with close contact and damage to the skin barrier, which is important to consider when preventing and controlling outbreaks. [4]
Who is affected and why: risk factors and routes of transmission
Transmission occurs through direct skin-to-skin contact with active lesions or through fomites, especially when there are micro-damages to the skin due to scratching, insect bites, abrasions, burns, and dermatitis. A warm, humid climate, overcrowding, and poor hygiene enhance transmission. [5]
Those at increased risk include preschool-aged children, people with itchy dermatoses, immunocompromised patients, and members of families and groups with close household contact. In such situations, outbreaks develop in "pathways" along scratches, and autoinfection spreads the pathogen to new areas. [6]
After the start of antibacterial treatment, infectivity rapidly decreases: in cases of streptococcal impetigo, a child may return to kindergarten or school, provided the lesions are adequately covered at least 12 hours after the start of antibiotic treatment and the lesions are covered with bandages. This is an essential part of family prevention. [7]
Bacterial resistance to topical antibiotics develops more rapidly with frequent or prolonged use. Therefore, in the case of relapses, swab cultures and a well-thought-out strategy are essential, including contact measures and, if necessary, nasal carriage assessment in cases of frequently recurring impetigo. [8]
What it looks like: clinical forms and their characteristics
Classic non-bullous impetigo begins with erythematous papules that quickly develop into vesicles and pustules; after rupture, erosions with characteristic "honey-colored" crusts form. Localization: the face, nasolabial triangle, extremities, and scratched areas. Healing is usually without scars. [9]
Bullous impetigo presents as thin-walled blisters caused by the desquamative toxins of Staphylococcus aureus; after rupture, shiny erosions with a rim of the blister cap remain. Although differentiation by pathogen is important for epidemiology, in primary care, isolation strategies and antibiotic selection are similar. [10]
Ecthyma is a deeper variant, in which ulcers with infiltration at the edges form beneath dense crusts; healing is often accompanied by scarring. Ecthyma is most often associated with Streptococcus pyogenes, but can be mixed. This is a key marker for systemic therapy. [11]
In pediatrics, streptococcal intertrigo is also noted—a bright red, macerated lesion in the folds of the neck, armpits, or groin with a strong odor and no "satellite" pustules, which distinguishes it from candidiasis. This form is often underestimated and disguised as diaper rash. [12]
Table 1. The main clinical forms of streptoderma and how they differ
| Form | Depth of damage | Typical appearance | Frequent localization | Scarring |
|---|---|---|---|---|
| Nonbullous impetigo | Superficially, epidermis | "Honey" crusts on erosions | Face, limbs, scratched areas | No |
| Bullous impetigo | Superficial, bubbles | Thin blisters, shiny erosions with a rim | Folds, torso, limbs | No |
| Ecthyma | Deeper, dermis | Dense crusts, with ulcers and infiltration underneath them | Shins, injury sites | Often yes |
| Streptococcal intertrigo | Superficially | Bright red maceration, sharp aroma, no "companions" | Neck in infants, armpits, groin | No |
Based on clinical guidelines and reviews. [13]
How to distinguish from other diseases: differential diagnostic keys
Nonbullous impetigo is differentiated from herpetic erosions, impetigophora dermatitis in children, chickenpox, and scabies. The formation of "honey" crusts, the absence of a teardrop-shaped distribution across dermatomes, and the presence of crusts at the site of ruptured pustules with a tendency to peripheral growth support a diagnosis of impetigo. [14]
Bullous impetigo must be distinguished from burns, contact dermatitis, and staphylococcal scalded skin syndrome, where the blisters are generalized and systemic symptoms are present. The latter requires urgent examination and hospitalization, unlike localized bullous impetigo, which is an outpatient condition. [15]
Ecthyma raises the question of venous trophic ulcers, necrotizing infections, and deep mycoses. Ecthyma is usually multiple, with crusts and relatively small ulcers against a background of a compromised skin barrier, whereas trophic ulcers are associated with an area of chronic venous insufficiency. [16]
Intertrigo in the folds must be distinguished from candidiasis: candidiasis is characterized by "satellite" pustules and the absence of a strong odor. When in doubt, a smear with staining and culture is helpful, which is especially important in cases of relapse or failure to respond to empirical therapy. [17]
Table 2. Differential diagnosis of superficial skin lesions
| Clinical situation | In favor of impetigo | In favor of an alternative diagnosis | What to rely on |
|---|---|---|---|
| Erosions with crusts in a child | Honey-colored crusts, peripheral growth | Vesicles along the dermatome, severe pain | Examination, anamnesis, epidemiological contacts |
| Bubbles | Local, thin caps, without severe intoxication | Widespread blisters, positive Nikolsky's sign | General signs, area of damage |
| Ulcers under the crusts | Small multiple ulcers on the shins | Large trophic ulcers with edema | Concomitant venous pathology |
| Fold damage | A bright red spot, without "companions", smell | Satellite pustules in candidiasis | Microscopy, culture |
Practical indications from dermatological sources. [18]
How is the diagnosis confirmed: what does the doctor do and what tests are needed?
In typical cases, diagnosis is made clinically based on the characteristic appearance of the lesions. This expedites the initiation of treatment and restriction of contact, which is especially important for children's groups and family outbreaks. [19]
Sampling for staining and culture is not mandatory in every situation, but is indicated in cases of relapse, failure of standard treatment, widespread lesions, and to determine the pathogen's sensitivity to antibiotics. This helps adjust therapy and avoid ineffective repeat courses. [20]
In cases of frequently recurring impetigo, it is recommended to take swabs from lesions and, if necessary, a nasal swab to assess carriage, while simultaneously considering decolonization measures according to local protocols. This approach reduces the risk of new outbreaks and decreases the need for antibiotics. [21]
If ecthyma or complications are suspected, or if the general condition is severe, an in-person assessment is indicated, and a decision on advanced diagnostics and systemic therapy is made. In questionable cases in immunocompromised patients, a skin biopsy may be required. [22]
Table 3. Diagnostic tactics for streptoderma
| Situation | What to do | For what |
|---|---|---|
| Typical localized impetigo | Clinical diagnosis, initiation of local therapy | Rapidly reduce infectivity and symptoms |
| Relapses or no response | Sowing from foci, revision of the scheme | Identify resistance, determine the pathogen |
| Frequent relapses | Consider nasal swab, decolonization measures | Reduce the frequency of exacerbations |
| Severe course, ecthyma | Evaluation for systemic therapy, biopsy if necessary | Rule out deep infections and complications |
Summary of guidelines for infectious disease specialists and dermatologists. [23]
Treatment: local therapy and care of lesions
For localized nonbullous impetigo, the initial strategy in some health systems is a 1% hydrogen peroxide antiseptic cream applied multiple times for 5 days. If this is unavailable, contraindicated, or the lesions are located near the eyes, a short course of topical antibiotics is chosen. [24]
Topical antibiotics with proven efficacy include fusidic acid 2% and mupirocin 2%. They are administered in divided doses over 5 days, taking into account local sensitivity. Repeated or prolonged courses are undesirable due to accelerated resistance development, so relapses require diagnostic testing and a review of treatment. [25]
Modern alternatives include retapamulin 1%, applied twice daily for 5 days and shown to be comparable to systemic therapy in several studies. Ozenoxacin 1%, with proven clinical and microbiological efficacy in short courses, is available for some patients, including young children. The choice of a specific agent depends on drug availability, age, and local resistance. [26]
It is important not to combine topical and oral antibiotics in the same outbreak unless specifically indicated. Concomitant use does not improve outcomes and increases the risk of resistance. Care of lesions includes careful removal of crusts after softening, covering with non-permeable dressings, and practicing hand hygiene in the household. [27]
Table 4. Topical first-line agents for localized nonbullous impetigo
| Means | Age Notes | Typical course | Comments on resistance |
|---|---|---|---|
| Hydrogen peroxide one percent cream | For children over 72 hours of life according to national protocols | 5 days | Initial therapy option for localized process |
| Fusidic acid two percent | Taking into account the instructions for the specific product | 5 days | Growing resistance requires caution with repeated courses |
| Mupirocin two percent | Discuss age restrictions for the product | 5 days | Use with caution, avoid prolonged use |
| Retapamulin one percent | Over 9 months | 5 days | Convenience due to double application |
| Ozenoxacin one percent | Older than 2 months | 5 days | Rapid microbiological response in trials |
Selection based on evidence and availability. [28]
When are oral antibiotics needed and what regimens are preferable?
Oral antibiotics are indicated for bullous impetigo, multiple lesions, ecthyma, systemic symptoms, failure to respond to topical therapy, and outbreaks to reduce transmission. This is justified both by reducing the risk of dissemination and by the potential role of Staphylococcus aureus. [29]
If methicillin-sensitive Staphylococcus aureus and Streptococcus pyogenes are suspected, antistaphylococcal penicillins, such as flucloxacillin or cephalexin, a first-generation cephalosporin, are preferred. In adults with penicillin intolerance, macrolides are acceptable, but local resistance data should be considered. [30]
If there is a risk of methicillin-resistant Staphylococcus aureus, clindamycin, doxycycline in patients over 8 years of age, or a combination of trimethoprim and sulfamethoxazole are considered. If culture reveals only Streptococcus pyogenes, phenoxymethylpenicillin is preferred. Duration is usually 5-7 days for impetigo and 7 days for ecthyma, with adjustments based on clinical findings. [31]
In pediatrics, doses are calculated in milligrams per kilogram of body weight and are selected by a physician based on age, body weight, and organ function. It is important to monitor tolerance, and if there is no improvement by the end of the course, return to the physician for a review of the diagnosis, evaluation of cultures, and a change in medication. [32]
Table 5. Indications for systemic therapy
| Indication | Why is this important? | What does a doctor do? |
|---|---|---|
| Bullous impetigo | Higher risk of dissemination and mixed etiology | Prescribes a short course of oral antibiotics |
| Numerous foci or large areas | Topical therapy is difficult to apply and control | Switching to a systemic antibiotic |
| Ecthyma | Deeper, risk of scarring | Systemic therapy, dressings, observation |
| No response to local exchange rate | Possible resistance or misdiagnosis | Sowing, change of drug |
| Outbreaks in a family or group | Reduce transmission | A system of measures, sometimes treatment of contacts according to indications |
Based on recommendations from infectious disease specialists and primary care systems. [33]
Table 6. Choice of systemic antibiotics for impetigo and ecthyma
| Clinical situation | Preferred options | Alternatives for intolerance | Notes |
|---|---|---|---|
| Suspected susceptible Staphylococcus aureus and Streptococcus pyogenes | Flucloxacillin or cephalexin | Clarithromycin in adults, according to local protocols | Consider local stability data |
| Suspected methicillin-resistant Staphylococcus aureus | Clindamycin, doxycycline for children over 8 years of age, trimethoprim plus sulfamethoxazole | Others according to local protocols | It is important not to forget about the streptococcal coating |
| Culture: only Streptococcus pyogenes | Phenoxymethylpenicillin | Macrolide or clindamycin if intolerant | Narrow coverage priority |
According to clinical recommendations of infectious disease specialists. [34]
Prevention of spread and home care
The key to breaking the chain of transmission is prompt initiation of antibacterial therapy, covering the affected areas with clean dressings, using separate towels, and regular hand hygiene by all family members. This reduces the risk of autoinfection and infection of others. [35]
Clear rules are important in children's groups: returning to the classroom is permitted after at least 12 hours from the start of the appropriate antibiotic, provided the lesions are closed and the child feels well. Staff and parents should be reminded to regularly clean surfaces and toys. [36]
Repeated courses of topical antibiotics without indication and long-term use increase the risk of resistance, so in case of frequent relapses it is better to perform microbiological clarification and discuss with the physician the strategy, including targeted therapy and consideration of decolonization in carriage. [37]
If you have underlying skin conditions, such as atopic dermatitis, preventing flare-ups of itching and scratching indirectly reduces the risk of further impetigo episodes. This includes moisturizing, treating the dermatitis, and controlling insects, especially during warmer months. [38]
Table 7. Simple rules that really reduce transmission
| Measure | What it looks like at home | For what |
|---|---|---|
| Early initiation of treatment | See a doctor at the first sign | Reduce infectivity faster |
| Closing of outbreaks | Breathable dressings, change when wet | Less contact with the environment |
| Personal hygiene | Separate towels, frequent hand washing | Reducing household transmission |
| Itch management | Short nails, emollients | Less scratching and new outbreaks |
Based on clinical logic and official prevention. [39]
Possible complications and when to see a doctor
Most episodes of streptoderma are mild, but rare immune complications are possible, particularly poststreptococcal glomerulonephritis, which develops 1-2 weeks after the skin infection. It presents with swelling, dark urine, and elevated blood pressure and requires immediate evaluation. [40]
It's important to understand that antibiotics prescribed for impetigo do not prevent the development of post-streptococcal glomerulonephritis, as it is an immune-mediated process. Fortunately, most children have a favorable prognosis, but adults experience a more severe complication. [41]
An urgent visit to the doctor is necessary if the lesions are widespread, there is a high fever, severe malaise, signs of cellulitis, deep tissue tenderness, and signs of dehydration in children. Monitoring and systemic therapy are essential for ecthyma due to the risk of scarring. [42]
Poststreptococcal glomerulonephritis remains rare in countries with high levels of healthcare, but outbreaks have been reported in various regions and are associated with the circulation of nephritogenic strains. This is another argument in favor of controlling impetigo outbreaks and promptly treating them. [43]
Table 8. Red flags requiring urgent assistance
| Sign | Why is it dangerous? | Action |
|---|---|---|
| Fever, apathy, refusal to drink in a child | Risk of invasive infection, dehydration | See a doctor immediately |
| Rapid spread of redness and pain | Possible cellulite | See a doctor immediately |
| Dark urine, swelling, headache | Risk of poststreptococcal glomerulonephritis | Immediate assessment |
| Deep tissue pain, large area blisters | Suspected severe toxin-mediated form | Emergency assistance |
According to clinical guidelines and reviews of complications. [44]
What about antibiotic resistance and “new” ointments?
Many countries have noted increasing resistance of Staphylococcus aureus to fusidic acid and a gradual increase in the proportion of strains resistant to mupirocin. This is one reason why short courses are recommended, and in case of relapses, the pathogen and its susceptibility are confirmed. [45]
Newer topical agents include retapamulin and ozenoxacin. Retapamulin is convenient for double application and has demonstrated good clinical efficacy in studies, including comparisons with systemic therapy for limited lesions. Ozenoxacin has demonstrated a rapid microbiological response and safety in children as young as 2 months. [46]
However, the choice of treatment is a balance of efficacy, local resistance, age, and availability. For localized disease, preference is given to short-course topical therapy; for widespread or blistering disease, preference is given to systemic therapy. This is reflected in the consensus recommendations of infectious disease specialists and primary care systems. [47]
Table 9. What to consider when choosing a topical drug
| Criterion | Notes |
|---|---|
| Child's age | The drugs have lower age limits |
| Local stability | In case of high resistance to fusidic acid, consider alternatives |
| Ease of application | Applying twice more often increases adherence |
| Repeated episodes | Sowing and relapse prevention strategy are needed |
Sum of data from clinical guidelines and resistance observations. [48]
Prognosis and return to normal life
With localized impetigo and timely treatment, the prognosis is favorable: the lesions heal in 7-10 days, usually without scars, and work capacity or attendance at a children's group is restored quickly if the rules of isolation and dressings are observed. [49]
Ecthyma requires closer monitoring due to the depth of the lesion and the risk of scarring. Timely administration of systemic antibiotics and proper wound care reduce ulcer depth and improve cosmetic results. [50]
In cases of recurrent infections, collaboration between the physician and family is essential: identify triggers, treat concomitant dermatoses, conduct microbiological testing if necessary, and discuss appropriate measures with the team. This reduces the frequency of episodes during the high-risk season. [51]
Most complications are rare with modern approaches, and if they do develop, prompt medical attention ensures a favorable outcome in the vast majority of children. Adult patients with suspected immune-related complications also require monitoring. [52]
Frequently asked questions
Is impetigo contagious and how long does isolation last
? Yes, it is contagious through direct contact and through objects. After starting an appropriate antibiotic, contagiousness quickly declines; in closed lesions, returning to a children's group is permitted after at least 12 hours from the start of treatment. [53]
Is it possible to cure the condition with ointments alone?
If the lesions are few and there are no blisters, a short course of topical therapy is sufficient. If there are blisters, multiple lesions, ecthyma, or if there is no response to ointment, oral antibiotics are needed. [54]
Should everyone be tested
? No. Culture is important in cases of relapse, lack of response, widespread lesions, and frequent episodes, when decolonization and narrow coverage are considered. [55]
Can post-streptococcal glomerulonephritis be prevented with antibiotics
? No, it is an immune-related complication. However, prompt treatment reduces the spread and severity of the skin process; if warning signs appear after impetigo, a doctor's evaluation is necessary. [56]
Table 10. Quick algorithm for suspected streptoderma
| Step | Action | Justification |
|---|---|---|
| 1 | Assess the form and prevalence | Solution: locally or internally |
| 2 | Start a short course as indicated | Rapid decline in infectivity |
| 3 | Discuss the rules at home and in the group | Transmission interruption |
| 4 | No answer by the end of the course - review | Sowing, correction of therapy |
A universal approach based on guidelines. [57]

